{"id":"https://openalex.org/W42226212","doi":"https://doi.org/10.1096/fasebj.23.1_supplement.592.18","title":"VEGFR2 Receptor Cleavage, Endothelial Apoptosis and Capillary Rarefaction in the Spontaneously Hypertensive Rat","display_name":"VEGFR2 Receptor Cleavage, Endothelial Apoptosis and Capillary Rarefaction in the Spontaneously Hypertensive Rat","publication_year":2009,"publication_date":"2009-04-01","ids":{"openalex":"https://openalex.org/W42226212","doi":"https://doi.org/10.1096/fasebj.23.1_supplement.592.18","mag":"42226212"},"language":"en","primary_location":{"id":"doi:10.1096/fasebj.23.1_supplement.592.18","doi":"https://doi.org/10.1096/fasebj.23.1_supplement.592.18","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.23.1_supplement.592.18","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-2","ki-jl-2","medline","norway-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112655420","display_name":"Edward D. Tran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward D Tran","raw_affiliation_strings":["Bioengineering University of California, San Diego La Jolla CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioengineering University of California, San Diego La Jolla CA","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055828264","display_name":"Geert W. Schmid\u2010Sch\u00f6nbein","orcid":"https://orcid.org/0000-0002-1803-1521","observed_orcids":["https://orcid.org/0000-0002-1803-1521"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Geert W Schmid\u2010Sch\u00f6nbein","raw_affiliation_strings":["Bioengineering University of California, San Diego La Jolla CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioengineering University of California, San Diego La Jolla CA","institution_ids":["https://openalex.org/I36258959"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I36258959"],"apc_list":{"value":3740,"currency":"USD","value_usd":3740},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.00422058,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"23","issue":"S1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.4814000129699707,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.4814000129699707,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.4611999988555908,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.011099999770522118,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/endothelial-cell-apoptosis","display_name":"endothelial cell apoptosis","score":0.9660000205039978},{"id":"https://openalex.org/keywords/capillary-rarefaction","display_name":"capillary rarefaction","score":1.0},{"id":"https://openalex.org/keywords/spontaneously-hypertensive-rats","display_name":"spontaneously hypertensive rats","score":0.9829999804496765},{"id":"https://openalex.org/keywords/matrix-metalloproteinases","display_name":"matrix metalloproteinases","score":0.8960000276565552},{"id":"https://openalex.org/keywords/mmp-1","display_name":"MMP-1","score":0.8870000243186951},{"id":"https://openalex.org/keywords/mmp-7","display_name":"MMP-7","score":0.7599999904632568},{"id":"https://openalex.org/keywords/mmp-9","display_name":"MMP-9","score":0.9739999771118164},{"id":"https://openalex.org/keywords/mmp-2","display_name":"MMP-2","score":0.6570000052452087},{"id":"https://openalex.org/keywords/mmp-8","display_name":"MMP-8","score":0.9679999947547913},{"id":"https://openalex.org/keywords/doxycycline","display_name":"doxycycline","score":0.7820000052452087},{"id":"https://openalex.org/keywords/mmp-inhibition","display_name":"matrix metalloproteinase inhibition","score":0.7129999995231628},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.7120000123977661},{"id":"https://openalex.org/keywords/microvascular-complications","display_name":"microvascular complications","score":0.8289999961853027},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor-receptor","display_name":"vascular endothelial growth factor receptor","score":0.7289999723434448}],"concepts":[{"id":"https://openalex.org/C109523444","wikidata":"https://www.wikidata.org/wiki/Q424216","display_name":"Matrix metalloproteinase","level":2,"score":0.7611205577850342},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.6511014103889465},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.6232779026031494},{"id":"https://openalex.org/C14858245","wikidata":"https://www.wikidata.org/wiki/Q18028241","display_name":"Kinase insert domain receptor","level":5,"score":0.6143434047698975},{"id":"https://openalex.org/C123012128","wikidata":"https://www.wikidata.org/wiki/Q5376430","display_name":"Endothelial stem cell","level":3,"score":0.5733149647712708},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5389450788497925},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5093446969985962},{"id":"https://openalex.org/C28406088","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Extracellular","level":2,"score":0.4605855345726013},{"id":"https://openalex.org/C175156509","wikidata":"https://www.wikidata.org/wiki/Q1990218","display_name":"Cleavage (geology)","level":3,"score":0.43406978249549866},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4285036027431488},{"id":"https://openalex.org/C2776992346","wikidata":"https://www.wikidata.org/wiki/Q111140","display_name":"Endothelium","level":2,"score":0.42196905612945557},{"id":"https://openalex.org/C189165786","wikidata":"https://www.wikidata.org/wiki/Q193825","display_name":"Extracellular matrix","level":2,"score":0.4208306074142456},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34295934438705444},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.3373069167137146},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3350660800933838},{"id":"https://openalex.org/C146285616","wikidata":"https://www.wikidata.org/wiki/Q7916455","display_name":"Vascular endothelial growth factor A","level":4,"score":0.2724621593952179},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.26193538308143616},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.24941545724868774},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.13238006830215454},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1197546124458313},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.07189646363258362},{"id":"https://openalex.org/C43369102","wikidata":"https://www.wikidata.org/wiki/Q2307625","display_name":"Fracture (geology)","level":2,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1096/fasebj.23.1_supplement.592.18","doi":"https://doi.org/10.1096/fasebj.23.1_supplement.592.18","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.23.1_supplement.592.18","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-2","ki-jl-2","medline","norway-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2354285071","https://openalex.org/W2360943677","https://openalex.org/W2606570811","https://openalex.org/W2514475733","https://openalex.org/W2010675318","https://openalex.org/W3197629135","https://openalex.org/W1971741722","https://openalex.org/W2150108534","https://openalex.org/W2426556017","https://openalex.org/W2354266349"],"abstract_inverted_index":{"The":[0,85,164],"spontaneously":[1],"hypertensive":[2],"rat":[3],"(SHR)":[4],"has":[5,24],"a":[6,89],"multitude":[7],"of":[8,27,72,93,96,103,119,123,178,188],"microvascular":[9,36,168],"complications":[10],"including":[11],"endothelial":[12,55,64,156,180],"apoptosis":[13,34,44,65],"with":[14],"capillary":[15,67,159,183],"rarefaction.":[16,68],"Our":[17,47],"recent":[18],"evidence":[19],"shows":[20],"that":[21,50,174],"the":[22,39,43,106,120,162],"SHR":[23,83,86],"elevated":[25,167],"levels":[26,71],"proteolytic":[28],"(matrix":[29],"metalloproteinases,":[30],"MMPs)":[31],"activity":[32],"and":[33,66,77,112,158,171,182],"in":[35,61,82,98,161,185],"cells,":[37],"but":[38],"molecular":[40],"mechanism":[41],"for":[42],"is":[45,49],"unknown.":[46],"hypothesis":[48],"selected":[51],"MMPs":[52],"cleave":[53],"vascular":[54],"growth":[56],"factor":[57],"receptor\u20102":[58],"(VEGFR2),":[59],"which":[60],"turn":[62],"causes":[63],"Significantly":[69],"enhanced":[70],"MMP\u20101,":[73,110,169],"\u20101/9,":[74,170],"\u20102,":[75],"\u20107,":[76,111],"\u20108":[78],"activities":[79,173],"were":[80],"observed":[81],"plasma.":[84],"also":[87],"had":[88],"significantly":[90],"lower":[91],"expression":[92],"extracellular":[94,121],"domains":[95],"VEGFR2":[97,154],"cardiac":[99],"microvessels.":[100],"Furthermore,":[101],"application":[102],"plasma":[104],"from":[105],"SHR,":[107],"or":[108,141],"purified":[109],"\u20109":[113],"to":[114],"nat\u00efve":[115],"cells":[116],"caused":[117],"cleavage":[118,127,177],"domain":[122],"VEGFR2.":[124],"This":[125],"receptor":[126],"was":[128],"blocked":[129],"by":[130,191],"broad":[131],"acting":[132],"MMP":[133,146],"inhibitors":[134],"(GM6001":[135],"1":[136],"\u00b5mol/L,":[137],"EDTA":[138],"10":[139],"mmol/L,":[140],"doxycycline":[142],"11.3":[143],"\u00b5mol/L).":[144],"Chronic":[145],"inhibition":[147],"(doxycycline,":[148],"5.4":[149],"mg/kg/day,":[150],"24":[151],"weeks)":[152],"attenuated":[153],"cleavage,":[155],"apoptosis,":[157,181],"rarefaction":[160,184],"SHR.":[163],"results":[165],"suggest":[166],"\u20107":[172],"may":[175],"cause":[176],"VEGFR2,":[179],"this":[186],"model":[187],"hypertension.":[189],"Supported":[190],"HL":[192],"10881.":[193]},"counts_by_year":[],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2025-10-10T00:00:00"}